A Randomized Study to Evaluate the Metabolic Responses of Adding Dapagliflozin Versus Sitagliptin to Chinese Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy (DISTINCTION Study)
Latest Information Update: 01 Aug 2023
At a glance
- Drugs Dapagliflozin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DISTINCTION
Most Recent Events
- 26 Jun 2023 Results of an analysis assessing changes in serum Thrombospondin-2 Level (TSP2) as a novel liver fibrosis biomarker presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
- 28 Apr 2021 Status changed from recruiting to completed.
- 24 May 2019 New trial record